home / stock / ebs / ebs articles

EBS Articles, Emergent Biosolutions Inc. - From 03/07/24

Stock Information
Company Name: Emergent Biosolutions Inc.
Stock Symbol: EBS
Market: NYSE
Website: emergentbiosolutions.com
Menu
EBS EBS Quote EBS Short EBS News EBS Articles EBS Message Board
Get EBS Alerts

News, Short Squeeze, Breakout and More Instantly...
Why Rush Street Interactive Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of Rush Street Interactive, Inc. (NYSE: RSI) rose sharply in today’s pre-market trading as the company reported better-than-expected...
Emergent BioSolutions Reports Q4 Results, Amends Credit Agreement | Benzinga

Emergent Biosolutions Inc (NYSE:EBS) shares are trading higher after the company amended its existing credit agreement and reported its fourth-quar...

Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024 | Benzinga

GAITHERSBURG, Md., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Wednesday, March 6, 2...

What's Going On Emergent BioSolutions Shares Today? | Benzinga

 Emergent BioSolutions, Inc. (NYSE:EBS) shares are trading lower in the premarket session on Thursday after ending yesterday’s run with a ...
Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-qu...

Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO | Benzinga

Papa will lead Emergent into a new era of focusing on protecting public health, returning to growth and paying down the company's debt GAIT...

Emergent BioSolutions Awarded Procurement Contract Valued up to $235.8 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of Defense | Benzinga

GAITHERSBURG, Md., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has secured an indefinite-del...
Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024 | Benzinga

GAITHERSBURG, Md., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE:EBS), a global company providing solutions that address public ...

What's Going On With Emergent Biosolutions Stock? | Benzinga

Emergent Biosolutions Inc (NYSE: EBS) shares initially traded higher Tuesday before pulling back and turning negative. The company received a ...

Emergent BioSolutions Reports Third Quarter 2023 Financial Results | Benzinga

Third Quarter 2023 Total Revenues of $271M, above the prior guidance range Third Quarter 2023 Pre-Tax Loss of  $(266)M and Adjusted EBITDA(2) of...
Previous 10 Next 10